MeiraGTx Holdings (MGTX) Other financing activities (2018 - 2025)
MeiraGTx Holdings posted quarterly Other financing activities of $19.3 million for Q4 2025, down 4.92% year-on-year from $20.3 million in Q4 2024, and up 237.43% on a QoQ basis from $5.7 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 8 years of Other financing activities data on file, last reported at $19.3 million in Q4 2025.
- For the quarter ending Q4 2025, Other financing activities fell 4.92% year-over-year to $19.3 million; the trailing twelve-month figure through Dec 2025 stood at $32.9 million (down 11.26% YoY), and the FY2025 full-year result was $19.4 million, down 15.23% from the prior year.
- Other financing activities for Q4 2025 stood at $19.3 million, up from $5.7 million in the prior quarter.
- Across five years, Other financing activities topped out at $22.5 million in Q4 2021 and bottomed at $206000.0 in Q4 2022.
- The 5-year median for Other financing activities is $5.7 million (2025), against an average of $7.5 million.
- The widest annual swing landed in 2022, when Other financing activities sank 99.08%; it then soared 1016.02% in 2023.
- A 5-year view of Other financing activities shows it stood at $22.5 million in 2021, then tumbled by 99.08% to $206000.0 in 2022, then jumped by 1016.02% to $2.3 million in 2023, then soared by 784.99% to $20.3 million in 2024, then declined by 4.92% to $19.3 million in 2025.
- The last three Other financing activities figures came in at $19.3 million (Q4 2025), $5.7 million (Q3 2025), and $5.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.35 Mn |
| Dec 31, 2025 | 19.35 Mn |
| Sep 30, 2025 | 5.73 Mn |
| Sep 30, 2025 | 5.73 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | 20.35 Mn |
| Dec 31, 2024 | 20.35 Mn |
| Sep 30, 2024 | 6.19 Mn |
| Sep 30, 2024 | 6.19 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Sep 30, 2023 | 6.77 Mn |
| Sep 30, 2023 | 6.77 Mn |
| Jun 30, 2023 | 7.27 Mn |
| Jun 30, 2023 | 7.27 Mn |
| Mar 31, 2023 | 5.20 Mn |
| Mar 31, 2023 | 5.20 Mn |
| Dec 31, 2022 | 206,000.00 |
| Dec 31, 2022 | 206,000.00 |
| Sep 30, 2022 | 6.94 Mn |
| Sep 30, 2022 | 6.94 Mn |
| Jun 30, 2022 | 7.30 Mn |
| Jun 30, 2022 | 7.30 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 22.49 Mn |
| Dec 31, 2021 | 22.49 Mn |
| Sep 30, 2021 | 5.39 Mn |
| Sep 30, 2021 | 5.39 Mn |
| Jun 30, 2021 | 5.42 Mn |
| Jun 30, 2021 | 5.42 Mn |
| Mar 31, 2021 | 4.96 Mn |
| Mar 31, 2021 | 4.96 Mn |
| Dec 31, 2020 | 4.60 Mn |
| Dec 31, 2020 | 4.60 Mn |
| Sep 30, 2020 | 3.74 Mn |
| Sep 30, 2020 | 3.74 Mn |
| Jun 30, 2020 | 5.06 Mn |
| Jun 30, 2020 | 5.06 Mn |
| Mar 31, 2020 | 5.68 Mn |
| Mar 31, 2020 | 5.68 Mn |
| Dec 31, 2019 | -796,753.00 |
| Dec 31, 2019 | -796,753.00 |
| Sep 30, 2019 | 3.51 Mn |
| Sep 30, 2019 | 3.51 Mn |
| Jun 30, 2019 | 4.39 Mn |
| Jun 30, 2019 | 4.39 Mn |
| Mar 31, 2019 | 2.93 Mn |
| Mar 31, 2019 | 2.93 Mn |
| Dec 31, 2018 | 18.06 Mn |
| Dec 31, 2018 | 18.06 Mn |